- GCTK Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-1/A Filing
GlucoTrack (GCTK) S-1/AIPO registration (amended)
Filed: 24 Oct 24, 4:06pm
Exhibit 24.2
POWER OF ATTORNEY
Each person whose signature appears below constitutes and appoints Paul Goode and James S. Cardwell, and each of them singly, his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign this Registration Statement on Form S-1 and any and all amendments (including post-effective amendments) thereto of Glucotrack, Inc. and to file the same, with all exhibits thereto and all other documents in connection therewith, with the Securities and Exchange Commission, granting unto each said attorney-in-fact and agents full power and authority to do and perform each and every act in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or either of them or their, his or her substitute or substitutes may lawfully do or cause to be done by virtue hereof.
Signature | Title | Date | ||
Chief Executive Officer and Director | ||||
Paul Goode | (principal executive officer) | |||
Chief Financial Officer | ||||
James S. Cardwell | (principal financial and accounting officer) | |||
/s/ Dr. Robert Fischell | ||||
Dr. Robert Fischell | Director | October 24, 2024 | ||
/s/ Luis J. Malave | ||||
Luis J. Malave | Director | October 24, 2024 | ||
Andrew Balo | Director | |||
John Ballantyne | Director | |||
Allen Danzig | Director | |||
/s/ Erin Carter | ||||
Erin Carter | Director | October 24, 2024 |